347 related articles for article (PubMed ID: 6940191)
21. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
Senior RM; Griffin GL; Perez HD; Webster RO
J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
[TBL] [Abstract][Full Text] [Related]
22. Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes.
Damerau B; Grünefeld E; Vogt W
Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):181-4. PubMed ID: 732894
[TBL] [Abstract][Full Text] [Related]
23. Biologically active complement (C5)-derived peptides and their relevance to disease.
Perez HD
Crit Rev Oncol Hematol; 1984; 1(3):199-225. PubMed ID: 6241542
[TBL] [Abstract][Full Text] [Related]
24. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
Hugli TE; Erickson BW
Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
[TBL] [Abstract][Full Text] [Related]
25. The primary structure of porcine C3a anaphylatoxin.
Corbin NC; Hugli TE
J Immunol; 1976 Sep; 117(3):990-5. PubMed ID: 956663
[TBL] [Abstract][Full Text] [Related]
26. The active site of C3a anaphylatoxin.
Caporale LH; Tippett PS; Erickson BW; Hugli TE
J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory properties of human C5a and C5a des Arg/ in mast cell-depleted human skin.
Swerlick RA; Yancey KB; Lawley TJ
J Invest Dermatol; 1989 Sep; 93(3):417-22. PubMed ID: 2527912
[TBL] [Abstract][Full Text] [Related]
28. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
Marder SR; Chenoweth DE; Goldstein IM; Perez HD
J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
[TBL] [Abstract][Full Text] [Related]
29. Biochemistry and biology of anaphylatoxins.
Hugli TE
Complement; 1986; 3(3):111-27. PubMed ID: 3542363
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.
Yancey KB; Lawley TJ; Dersookian M; Harvath L
J Invest Dermatol; 1989 Feb; 92(2):184-9. PubMed ID: 2493055
[TBL] [Abstract][Full Text] [Related]
31. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
Stimler NP; Bach MK; Bloor CM; Hugli TE
J Immunol; 1982 May; 128(5):2247-52. PubMed ID: 6174625
[TBL] [Abstract][Full Text] [Related]
32. A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin.
Swerlick RA; Yancey KB; Lawley TJ
J Immunol; 1988 Apr; 140(7):2376-81. PubMed ID: 3351304
[TBL] [Abstract][Full Text] [Related]
33. The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.
Barker MD; Jose PJ; Williams TJ; Burton DR
Biochem J; 1986 Jun; 236(2):621-4. PubMed ID: 3019322
[TBL] [Abstract][Full Text] [Related]
34. Endotoxin-induced shock in the rat. A role for C5a.
Smedegård G; Cui LX; Hugli TE
Am J Pathol; 1989 Sep; 135(3):489-97. PubMed ID: 2789475
[TBL] [Abstract][Full Text] [Related]
35. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
Haeger M; Bengtson A; Karlsson K; Heideman M
Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
[TBL] [Abstract][Full Text] [Related]
36. Anaphylatoxin-mediated regulation of human and murine immune responses.
Morgan EL; Weigle WO; Hugli TE
Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.
Schulman ES; Post TJ; Henson PM; Giclas PC
J Clin Invest; 1988 Mar; 81(3):918-23. PubMed ID: 2449462
[TBL] [Abstract][Full Text] [Related]
38. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome.
Weinberg PF; Matthay MA; Webster RO; Roskos KV; Goldstein IM; Murray JF
Am Rev Respir Dis; 1984 Nov; 130(5):791-6. PubMed ID: 6497161
[TBL] [Abstract][Full Text] [Related]
39. Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin).
Perez HD; Kelly E; Chenoweth D; Elfman F
J Clin Invest; 1988 Jul; 82(1):360-3. PubMed ID: 3392212
[TBL] [Abstract][Full Text] [Related]
40. Rapid and simple measurement of human C5a-des-Arg level in plasma or serum using monoclonal antibodies.
Takeda J; Kinoshita T; Takata Y; Kozono H; Tanaka E; Hong K; Inoue K
J Immunol Methods; 1987 Aug; 101(2):265-70. PubMed ID: 3611800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
